New program aims to restore sexual function after prostate cancer surgery

NCT ID NCT07576335

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests whether a combination of a daily erectile medication, pelvic floor exercises, aerobic exercise, dietary advice, and mental health support can improve erectile function and urinary control in men after robot-assisted prostate removal for prostate cancer. Sixty-four men will be randomly assigned to either the program plus standard care or standard care alone. The study is conducted virtually and aims to find a scalable, low-cost way to improve recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Tadalafil 5 mg (a low-dose erectile medication) plus pelvic floor muscle training, aerobic exercise, dietary guidance, and psychological support

What this could lead to

If it works, this could provide a practical, low-cost program to help men recover erectile and urinary function after prostate surgery.

What could go wrong

This is a small, early-phase trial with only 64 participants, so results may not apply to everyone. The program is self-directed, so adherence may vary.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

erectile dysfunction prostate cancer Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Chris O'Brien Lifehouse

    Sydney, New South Wales, 2050, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Concord Repatriation General Hospital (CRGH)

    Sydney, New South Wales, 2139, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Royal Prince Alfred Hospital

    Sydney, New South Wales, 2050, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••